Skip to main content
. Author manuscript; available in PMC: 2012 Jun 6.
Published in final edited form as: Clin Cancer Res. 2008 Oct 1;14(19):6317–6323. doi: 10.1158/1078-0432.CCR-08-0539

Table 3.

ORRs to chemotherapy and erlotinib or chemotherapy and placebo according to EGFR gene copy number by FISH

EGFR FISH (+) EGFR FISH (−)


Chemotherapy +
erlotinib (n = 43)
Chemotherapy +
placebo (n = 57)
Chemotherapy +
erlotinib (n = 78)
Chemotherapy +
placebo (n = 67)
ORR 5 (11.6) 17 (29.8) 17 (21.8) 17 (25.4)
95% CI 4.7–25.0 18.4–42.4 13.9–32.4 15.8–36.8
P 0.0495 0.6954

All data n (%), unless otherwise noted.

HHS Vulnerability Disclosure